{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:19:11Z","timestamp":1793387951176,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81901285"],"award-info":[{"award-number":["81901285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81701726"],"award-info":[{"award-number":["81701726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Science and Technology of China","award":["2018YFC1312001"],"award-info":[{"award-number":["2018YFC1312001"]}]},{"name":"Ministry of Science and Technology of China","award":["2021YFC2501200"],"award-info":[{"award-number":["2021YFC2501200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Abnormal activation of immune system is an important pathogenesis of Parkinson\u2019s disease, but the relationship between peripheral inflammation, central microglia activation and dopaminergic degeneration remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the brain regional microglia activation and its relationship with clinical severity, dopaminergic presynaptic function, and peripheral inflammatory biomarkers related to adaptive immunity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this case\u2013control study, we recruited 23 healthy participants and 24 participants with early-stage Parkinson\u2019s disease.\n                      <jats:sup>18<\/jats:sup>\n                      F-PBR06 PET\/MR for microglia activation,\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-DTBZ for dopaminergic denervation, total account of T cells and subpopulations of T helper (Th1\/Th2\/Th17) cells, and the levels of serum inflammatory cytokines were assessed. Sanger sequencing was used to exclude the mix-affinity binders of\n                      <jats:sup>18<\/jats:sup>\n                      F-PBR06-PET.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to healthy controls, patients with Parkinson\u2019s disease had an increased\n                      <jats:sup>18<\/jats:sup>\n                      F-PBR06-PET standardized uptake value ratio (SUVR) in the putamen, particularly in the ipsilateral side of the motor onset.\n                      <jats:sup>18<\/jats:sup>\n                      F-PBR06-PET SUVR was positively associated with\n                      <jats:sup>18<\/jats:sup>\n                      F-FP-DTBZ-PET SUVR in the brainstem and not associated with disease severity measured by Hoehn and Yahr stage, MDS-UPDRS III scores. Patients with Parkinson\u2019s disease had elevated frequencies of Th1 cells and serum levels of IL10 and IL17A as compared to healthy controls. No significant association between peripheral inflammation markers and microglia activation in the brain of PD was observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease is associated with early putaminal microglial activation and peripheral phenotypic Th1 bias. Peripheral adaptive immunity might be involved in microglia activation in the process of neurodegeneration in PD indirectly, which may be a potential biomarker for the early detection and the target for immunomodulating therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-022-02574-z","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T03:06:09Z","timestamp":1661742369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Brain microglia activation and peripheral adaptive immunity in Parkinson\u2019s disease: a multimodal PET study"],"prefix":"10.1186","volume":"19","author":[{"given":"Shu-Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Xia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Song","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Barret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ning","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles D.","family":"Tamagnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Sossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"issue":"10291","key":"2574_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"8","key":"2574_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38(8):1285\u201391.","journal-title":"Neurology"},{"issue":"6","key":"2574_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol. 2003;106(6):518\u201326.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"2574_CR4","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s10072-017-2988-4","volume":"38","author":"S Jiang","year":"2017","unstructured":"Jiang S, Gao H, Luo Q, Wang P, Yang X. The correlation of lymphocyte subsets, natural killer cell, and Parkinson\u2019s disease: a meta-analysis. Neurol Sci. 2017;38(8):1373\u201380.","journal-title":"Neurol Sci"},{"issue":"11","key":"2574_CR5","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y. Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 2016;73(11):1316\u201324.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2574_CR6","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, et al. I Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Investig. 2009;119(1):182\u201392.","journal-title":"J Clin Investig"},{"issue":"7660","key":"2574_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, et al. T cells from patients with Parkinson\u2019s disease recognize alpha-synuclein peptides. Nature. 2017;546(7660):656\u201361.","journal-title":"Nature"},{"issue":"5","key":"2574_CR8","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","volume":"184","author":"AD Reynolds","year":"2010","unstructured":"Reynolds AD, Stone DK, Hutter JA, Benner EJ, Mosley RL, Gendelman HE. Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease. J Immunol. 2010;184(5):2261\u201371.","journal-title":"J Immunol"},{"issue":"1","key":"2574_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer A, Maxreiter F, Krach F, Fadler T, Grosch J, Maroni M, et al. Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson\u2019s disease. Cell Stem Cell. 2018;23(1):123-31.e6.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2574_CR10","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s00415-021-10877-z","volume":"269","author":"PF Zhang","year":"2022","unstructured":"Zhang PF, Gao F. Neuroinflammation in Parkinson\u2019s disease: a meta-analysis of PET imaging studies. J Neurol. 2022;269(5):2304\u201314.","journal-title":"J Neurol"},{"issue":"2","key":"2574_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2967\/jnumed.114.141713","volume":"57","author":"L Vivash","year":"2016","unstructured":"Vivash L, O\u2019Brien TJ. Imaging microglial activation with TSPO PET: lighting up neurologic diseases? J Nucl Med. 2016;57(2):165\u20138.","journal-title":"J Nucl Med"},{"issue":"2","key":"2574_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, et al. Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol. 2005;57(2):168\u201375.","journal-title":"Ann Neurol"},{"issue":"1","key":"2574_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","volume":"19","author":"S Iannaccone","year":"2013","unstructured":"Iannaccone S, Cerami C, Alessio M, Garibotto V, Panzacchi A, Olivieri S, et al. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2013;19(1):47\u201352.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"2574_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/npp.2012.255","volume":"38","author":"P Edison","year":"2013","unstructured":"Edison P, Ahmed I, Fan Z, Hinz R, Gelosa G, Ray Chaudhuri K, et al. Microglia, amyloid, and glucose metabolism in Parkinson\u2019s disease with and without dementia. Neuropsychopharmacology. 2013;38(6):938\u201349.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2574_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis. 2006;21(2):404\u201312.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"2574_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/jon.12519","volume":"28","author":"Y Kang","year":"2018","unstructured":"Kang Y, Mozley PD, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, et al. Noninvasive PK11195-PET image analysis techniques can detect abnormal cerebral microglial activation in Parkinson\u2019s disease. J Neuroimaging. 2018;28(5):496\u2013505.","journal-title":"J Neuroimaging"},{"issue":"8","key":"2574_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12149-016-1099-2","volume":"30","author":"T Terada","year":"2016","unstructured":"Terada T, Yokokura M, Yoshikawa E, Futatsubashi M, Kono S, Konishi T, et al. Extrastriatal spreading of microglial activation in Parkinson\u2019s disease: a positron emission tomography study. Ann Nucl Med. 2016;30(8):579\u201387.","journal-title":"Ann Nucl Med"},{"key":"2574_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","volume":"82","author":"S Lavisse","year":"2021","unstructured":"Lavisse S, Goutal S, Wimberley C, Tonietto M, Bottlaender M, Gervais P, et al. Increased microglial activation in patients with Parkinson disease using [(18)F]-DPA714 TSPO PET imaging. Parkinsonism Relat Disord. 2021;82:29\u201336.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"2574_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12974-016-0778-1","volume":"14","author":"C Ghadery","year":"2017","unstructured":"Ghadery C, Koshimori Y, Coakeley S, Harris M, Rusjan P, Kim J, et al. Microglial activation in Parkinson\u2019s disease using [(18)F]-FEPPA. J Neuroinflamm. 2017;14(1):8.","journal-title":"J Neuroinflamm"},{"issue":"9","key":"2574_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138721","volume":"10","author":"Y Koshimori","year":"2015","unstructured":"Koshimori Y, Ko JH, Mizrahi R, Rusjan P, Mabrouk R, Jacobs MF, et al. Imaging striatal microglial activation in patients with Parkinson\u2019s disease. PLoS ONE. 2015;10(9): e0138721.","journal-title":"PLoS ONE"},{"issue":"2","key":"2574_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00259-018-4161-6","volume":"46","author":"K Varn\u00e4s","year":"2019","unstructured":"Varn\u00e4s K, Csel\u00e9nyi Z, Jucaite A, Halldin C, Svenningsson P, Farde L, et al. PET imaging of [(11)C]PBR28 in Parkinson\u2019s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding. Eur J Nucl Med Mol Imaging. 2019;46(2):367\u201375.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"2574_CR22","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord"},{"issue":"1","key":"2574_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32(1):1\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2574_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.parkreldis.2020.07.017","volume":"78","author":"H Zhang","year":"2020","unstructured":"Zhang H, Wang T, Li Y, Mao W, Hao S, Huang Z, et al. Plasma immune markers in an idiopathic REM sleep behavior disorder cohort. Parkinsonism Relat Disord. 2020;78:145\u2013501.","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"2574_CR25","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.steroids.2011.06.012","volume":"76","author":"M Wang","year":"2011","unstructured":"Wang M, Gao M, Miller KD, Zheng QH. Synthesis of [11C]PBR06 and [18F]PBR06 as agents for positron emission tomographic (PET) imaging of the translocator protein (TSPO). Steroids. 2011;76(12):1331\u201340.","journal-title":"Steroids"},{"key":"2574_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.824152","volume":"16","author":"Y Shan","year":"2022","unstructured":"Shan Y, Wang Z, Song S, Xue Q, Ge Q, Yang H, et al. Integrated positron emission tomography\/magnetic resonance imaging for resting-state functional and metabolic imaging in human brain: what is correlated and what is impacted. Front Neurosci. 2022;16: 824152.","journal-title":"Front Neurosci"},{"key":"2574_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.931015","volume":"14","author":"XL Liu","year":"2022","unstructured":"Liu XL, Liu SY, Barret O, Tamagnan GD, Qiao HW, Song TB, et al. Diagnostic value of striatal 18F-FP-DTBZ PET in Parkinson\u2019s disease. Front Aging Neurosci. 2022;14: 931015.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2574_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13550-016-0226-3","volume":"6","author":"A Nair","year":"2016","unstructured":"Nair A, Veronese M, Xu X, Curtis C, Turkheimer F, Howard R, et al. Test\u2013retest analysis of a non-invasive method of quantifying [11C]-PBR28 binding in Alzheimer\u2019s disease. EJNMMI Res. 2016;6(1):72.","journal-title":"EJNMMI Res"},{"issue":"9","key":"2574_CR29","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1097\/RLU.0000000000002179","volume":"43","author":"T Singhal","year":"2018","unstructured":"Singhal T, O\u2019Connor K, Dubey S, Belanger AP, Hurwitz S, Chu R, et al. 18F-PBR06 versus 11C-PBR28 PET for assessing white matter translocator protein binding in multiple sclerosis. Clin Nucl Med. 2018;43(9):e289\u201395.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"2574_CR30","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1474-4422(17)30173-4","volume":"16","author":"MG Stokholm","year":"2017","unstructured":"Stokholm MG, Iranzo A, Ostergaard K, Serradell M, Otto M, Svendsen KB, et al. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case\u2013control study. Lancet Neurol. 2017;16(10):789\u201396.","journal-title":"Lancet Neurol"},{"issue":"8","key":"2574_CR31","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1007\/s00415-020-09830-3","volume":"267","author":"MG Stokholm","year":"2020","unstructured":"Stokholm MG, Garrido A, Tolosa E, Serradell M, Iranzo A, \u00d8stergaard K, et al. Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers. J Neurol. 2020;267(8):2296\u2013300.","journal-title":"J Neurol"},{"issue":"3","key":"2574_CR32","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/mds.28375","volume":"36","author":"S Mullin","year":"2021","unstructured":"Mullin S, Stokholm MG, Hughes D, Mehta A, Parbo P, Hinz R, et al. Brain microglial activation increased in glucocerebrosidase (GBA) mutation carriers without Parkinson\u2019s disease. Mov Disord. 2021;36(3):774\u20139.","journal-title":"Mov Disord"},{"key":"2574_CR33","volume-title":"Kuby immunology","author":"J Punt","year":"2018","unstructured":"Punt J, Stranford SA, Jones PP, Owen JA. Kuby immunology. 8th ed. New York: W. H. Freeman and Company; 2018.","edition":"8"},{"issue":"1","key":"2574_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, et al. Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients. J Neuroinflam. 2018;15(1):205.","journal-title":"J Neuroinflam"},{"issue":"10","key":"2574_CR35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2020858118","volume":"118","author":"K Farmen","year":"2021","unstructured":"Farmen K, Nissen SK, Stokholm MG, Iranzo A, \u00d8stergaard K, Serradell M, et al. Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder. Proc Natl Acad Sci USA. 2021;118(10): e2020858118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2574_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbi.2016.01.019","volume":"54","author":"N Kanegawa","year":"2016","unstructured":"Kanegawa N, Collste K, Forsberg A, Schain M, Arakawa R, Jucaite A, et al. In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects. Brain Behav Immun. 2016;54:149\u201357.","journal-title":"Brain Behav Immun"},{"issue":"12","key":"2574_CR37","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/brain\/awy265","volume":"141","author":"A Surendranathan","year":"2018","unstructured":"Surendranathan A, Su L, Mak E, Passamonti L, Hong YT, Arnold R, et al. Early microglial activation and peripheral inflammation in dementia with Lewy bodies. Brain. 2018;141(12):3415\u201327.","journal-title":"Brain"},{"issue":"7","key":"2574_CR38","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2967\/jnumed.108.060186","volume":"50","author":"Y Fujimura","year":"2009","unstructured":"Fujimura Y, Zoghbi SS, Simeon FG, Taku A, Pike VW, Innis RB, et al. Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06. J Nucl Med. 2009;50(7):1047\u201353.","journal-title":"J Nucl Med"},{"issue":"12","key":"2574_CR39","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1177\/1352458519867320","volume":"26","author":"E Herranz","year":"2020","unstructured":"Herranz E, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Mangeat G, et al. Profiles of cortical inflammation in multiple sclerosis by (11)C-PBR28 MR-PET and 7 Tesla imaging. Mult Scler. 2020;26(12):1497\u2013509.","journal-title":"Mult Scler"},{"issue":"Pt 3","key":"2574_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/brain\/awu377","volume":"138","author":"ML Loggia","year":"2015","unstructured":"Loggia ML, Chonde DB, Akeju O, Arabasz G, Catana C, Edwards RR, et al. Evidence for brain glial activation in chronic pain patients. Brain. 2015;138(Pt 3):604\u201315.","journal-title":"Brain"},{"issue":"32","key":"2574_CR41","doi-asserted-by":"publisher","first-page":"10809","DOI":"10.1523\/JNEUROSCI.1487-12.2012","volume":"32","author":"S Lavisse","year":"2012","unstructured":"Lavisse S, Guillermier M, H\u00e9rard A-S, Petit F, Delahaye M, Camp NV, et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci. 2012;32(32):10809\u201318.","journal-title":"J Neurosci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02574-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-022-02574-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02574-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T04:07:09Z","timestamp":1661746029000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-022-02574-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2574"],"URL":"https:\/\/doi.org\/10.1186\/s12974-022-02574-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"15 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed consent and the study was approved by the Clinical Research Ethics Board of Xuanwu Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The paper has not been published previously and is not under consideration for publication elsewhere. All coauthors have read and approved the submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}